Long-term follow-up study of vigabatrin in the treatment of refractory epilepsy

Grove, 1980, Increased CSF gamma-aminobutyric acid after treatment with gamma-vinyl-GABA, Lancet, 2, 647, 10.1016/S0140-6736(80)90318-9 Grove, 1981, Increased gamma-aminobutyric acid (GABA), homocarnosine and beta-alanine in cerebrospinal fluid of patients treated with gamma-vinyl-GABA (4-amino-hex-5-enoic acid), Life Sci, 28, 2431, 10.1016/0024-3205(81)90511-7 Jung, 1977, Gamma-vinyl-GABA (4 amino-hex-5-enoic acid), new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice, J Neurochem, 29, 797, 10.1111/j.1471-4159.1977.tb10721.x Perry, 1979, Gamma-vinyl-GABA: effects of chronic administration on the metabolism of GABA and other amino compounds in rat brain, J Neurochem, 32, 1641, 10.1111/j.1471-4159.1979.tb02274.x Schechter, 1984, Biochemical and clinical effects of gamma-vinyl-GABA in patients with epilepsy, Neurology, 34, 182, 10.1212/WNL.34.2.182 Browne, 1987, Vigabatrin for refractory complex partial seizures: multicenter single-blind study with long-term follow-up, Neurology, 37, 184, 10.1212/WNL.37.2.184 Gram, 1985, Gamma-vinyl-GABA: a double-blind placebo-controlled trial in partial epilepsy, Ann Neurol, 17, 262, 10.1002/ana.410170307 Grant, 1991, Vigabatrin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control, Drugs, 41, 889, 10.2165/00003495-199141060-00007 Loiseau, 1986, Double-blind, placebo controlled study of vigabatrin (gamma vinyl-GABA) in drug-resistant epilepsy, Epilepsia, 27, 115, 10.1111/j.1528-1157.1986.tb03512.x Michelucci, 1989, Response to vigabatrin in relation to seizure type, Br J Clin Pharmacol, 27, 119S, 10.1111/j.1365-2125.1989.tb03472.x Mumford, 1989, Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy, Br J Clin Pharmacol, 27, 101S, 10.1111/j.1365-2125.1989.tb03469.x Reynolds, 1988, A controlled trial of gamma-vinyl-GABA (vigabatrin) in drug resistant epilepsy, Br J Clin Pract, 42, 33 Rimmer, 1984, Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy, Lancet, 1, 189, 10.1016/S0140-6736(84)92112-3 Tartara, 1986, Vigabatrin in the treatment of epilepsy: a double-blind, placebo-controlled study, Epilepsia, 27, 717, 10.1111/j.1528-1157.1986.tb03600.x Tassinari, 1987, Double-blind study of vigabatrin in the treatment of drug resistant epilepsy, Arch Neurol, 44, 688, 10.1001/archneur.1987.00520210009010 Michelucci, 1992, Single-blind, placebo-controlled dose-modification study of vigabatrin in refractory epileptic patients, J Epilepsy, 5, 248, 10.1016/S0896-6974(05)80125-2 Browne, 1991, Multicenter long-term safety and efficacy study of vigabatrin for refractory complex partial seizures: an update, Neurology, 41, 363, 10.1212/WNL.41.3.363 Cocito, 1989, Vigabatrin in complex parital seizures: a long-term study, Epilepsy Res, 3, 160, 10.1016/0920-1211(89)90044-2 Remy, 1989, Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy, Br J Clin Pharmacol, 27, 125S, 10.1111/j.1365-2125.1989.tb03473.x Sivenius, 1991, Vigabatrin in drug-resistant partial epilepsy: a 5-year follow-up study, Neurology, 41, 562, 10.1212/WNL.41.4.562 Tartara, 1989, Vigabatrin in the treatment of epilepsy: a long-term follow-up study, J Neurol Neurosurg Psychiatry, 52, 467, 10.1136/jnnp.52.4.467 Pitkanen, 1993, Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients: a 5-year follow-up study, Arch Neurol, 50, 24, 10.1001/archneur.1993.00540010020012 Graham, 1989, Neuropathology of vigabatrin, Br J Clin Pharmacol, 27, 43S, 10.1111/j.1365-2125.1989.tb03460.x Rimmer, 1989, Interaction between vigabatrin and phenytoin, Br J Clin Pharmacol, 27, 27S, 10.1111/j.1365-2125.1989.tb03458.x Gatti, 1993, Vinyl GABA (vigabatrin) does not affect gastrointestinal absorption of phenytoin in epileptic patients, Epilepsia, 34, 120